LoginSignup
Almirall logo

Almirall

Stock
Stock
ISIN: ES0157097017
Ticker: ALM
ES0157097017
ALM

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Almirall has so far distributed $0.218 in 2026. The next dividend will be paid on 25.05.2027

$0.28

CHART BY

Frequently asked questions

The market capitalization of Almirall is $2.56B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Almirall is 36.93. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Almirall's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.318. EPS indicates the company's profitability on a per-share basis.
Currently, 14 analysts cover Almirall's stock, with a consensus target price of $16.78. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Almirall reported a revenue of $1.33B.
Almirall's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $285.75M. EBITDA measures the company's overall financial performance.
Almirall has a free cash flow of $242.41M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Almirall employs approximately 2,108 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of Almirall is 75.55M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$2.56B
EPS (TTM) 
$0.318
Free Float 
75.55M
P/E ratio (TTM) 
36.93
Revenue (TTM) 
$1.33B
EBITDA (TTM) 
$285.75M
Free Cashflow (TTM) 
$242.41M

Pricing

1D span
$11.73$11.92
52W span
$11.66$16.46

Analyst Ratings

The price target is $16.78 and the stock is covered by 14 analysts.

Buy

12

Hold

2

Sell

0

Information

Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network(Europe), Marketing through Own Network(United States), Marketing by Licensees, Research and Development Activity, and Corporate and Manufacturing services segments. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Employees
2,108
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
ES0157097017
Primary Ticker
ALM

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin